Pfizer Corporation

Hylar Lewis Friedman

William John Curatolo

Richard W Korsmeyer

Steven R LeMott

George H Foulds

Dwayne Thomas Friesen

Scott Max Herbig

James Blair West

Mary T Am Ende

Ravi Mysore Shankar

A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising administering azithromycin in such a controlled-release dosage form to a mammal, including a human patient, in need of such treatment.

Controlled-release dosage forms of azithromycin

An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages containing the dosage forms.

Method of administering azithromycin

Sustained release dosage forms of sertraline which release sertraline at a rate between 1 mgA/hr and 40 mgA/hr. The dosage forms may exhibit an initial delay period during which sertraline is released at a rate less than 1 mgA/hr.

Sertraline salts and sustained-release dosage forms of sertraline

Controlled-release dosage forms of Azithromycin

Growing community of inventors

Brattleboro, VT, United States of America

Hylar Lewis Friedman